Sign in
4

Changes in Ownership

Monte Rosa Therapeutics, Inc. Filed Acc 0001193125-26-156981

President & CEO sold 8,000 shares at $17.64 ($141,125)

From the SEC's structured data for this filing

Trades in this filing

Warmuth Markus · President & CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-04-14 Sale : show line 1 in the form −8,000 $17.64 $141,125 605,471 D
Open-market sales · 8,000 sh · avg $17.64 · $141,125
Loading xslF345X06/ownership.xml…